Conclusion: Overall, eszopiclone and lemborexant had a favorable profile, but eszopiclone might cause substantial adverse events and safety data on lemborexant were inconclusive. Doxepin, seltorexant, and zaleplon were well tolerated, but data on efficacy and other important outcomes were scarce and do not allow firm conclusions. Many licensed drugs (including benzodiazepines, daridorexant, suvorexant, and trazodone) can be effective in the acute treatment of insomnia but are associated with poor tolerability, or information about long-term effects is not available. Melatonin, ramelteon, and non-licensed
Melatonin side effects
Across 1,370 first-hand reports, people mentioned a side effect 286 times (about 21 per 100 reports). The most common: drowsiness, vivid dreams, fatigue. User reports show what people notice — they can't tell you whether Melatonin is safe for you.
Reported side effects
drowsiness127
vivid dreams86
fatigue30
depression17
brain fog15
headache6
suppression3
stomach issues2
What got worse for some people
In their own words
“I have taken it nightly for 19 years. Doses ranging from .1 to 10mg. Right now I take 3mg per night. It helps me sleep.”
“A small dose 0.3mg works for me way better than higher doses.”
“I used to take 50 mg before bedtime but now run out of it and use Dramamine instead. Sleep 8 hours. But with Melatonin dreams are more colourful.”
“I have been taking melatonin nightly for 20 years... I sleep so easily and deeply now... no real negative effects.”
“tabs are 3mg, so I cut one into quarters and took that the past 2 nights. Slept sooo much better and felt much more restored each morning.”
“it gave me vivid nightmares and restless sleep, then difficulty being alert the next day.”
Is Melatonin safe? What the research covers
AResearch: Strong688 meta-analyses · 1,128 randomized trials on PubMed
Lancet · 2022
Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysisCrit Care Med · 2025
Melatonin Use in the ICU: A Systematic Review and Meta-AnalysisConclusion: Our findings suggest that melatonin administration in the critically ill may improve perceived sleep and reduce delirium, without increasing adverse effects. Certainty of evidence was negatively affected by the risk of bias and inconsistency. Future RCTs should focus on identifying optimal dosing, administration timing, improving measurements of sleep outcomes, and target populations.
Sleep Med Rev · 2023
Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis